Herspiegel Promotes Santosh Naik to Partner

    Santosh Naik will lead the launch practice and leverage his experience to meet the growing demand for Contract Commercial Services.

    YARDLEY, Penn. – January, 2023 – Herspiegel, a leading provider of commercial strategy and implementation services to pharmaceutical and biotech industries, announced today that seasoned executive, Santosh Naik has been promoted to Partner. In his new role, Santosh will lead the Launch Practice while continuing to grow the commercialization services team, using his experience for solving critical business issues for clients ranging from start-ups to large pharmaceutical and biotech firms.

    “Our clients come to us because they want to leverage best practices from a tenured team that has launched more than 100 pharmaceutical products,” said Brent Herspiegel, Founder and President of Herspiegel. “In the last decade, Herspiegel has invested in growing our team and expanding our capabilities. Santosh has played an impactful role in the firm’s growth by successfully launching drugs and therapies for companies of all sizes, across multiple therapeutic areas including oncology, rare disease, psychiatry, neurology, migraine, women’s health, and pain management. As partner Santosh will continue to use his experience to support our clients as they launch future assets in a wide variety of therapeutic areas.”

    Santosh has played a key role in evolving our contract commercialization services to accelerate and de-risk launches for our biotech and pharmaceutical clients. He has successfully advised clients on over 20 unique assets as they prepared for launch. Santosh has also been a strategic advisor for biotech companies in building their infrastructure to successfully launch their first asset.

    “I am dedicated to advising our clients in a climate where regulatory, clinical, and marketing conditions are constantly changing. I am energized by the groundbreaking therapies being developed by our clients and working with their leadership teams on designing innovative go-to-market strategies that support positive patient outcomes,” said Santosh about his promotion. “For me, the foundation of Herspiegel’s success has been the investment in their employees professional and personal growth. It’s an exciting time to be part of Herspiegel and I am looking forward to what’s next for myself as well as for the firm.”

    Prior to joining Herspiegel, Santosh held positions at Forest Labs, later acquired by Actavis, and Becton Dickinson, a leading medical device company.  He holds an MBA in pharmaceutical marketing from Rutgers University and a BS in biomedical engineering from Georgia Tech.

    About Herspiegel

    Herspiegel is a leading consulting firm that specializes in the pharmaceutical, biotech, and medical device industries. We help our clients define impactful strategic approaches, streamline launch and commercialization processes, enhance business intelligence, and optimize product performance. Our service offerings include strategy and execution in launch readiness, marketing, market access, medical affairs, and patient services. Herspiegel clients span start-ups executing first commercialization to Fortune 500 pharmaceuticals with projects across primary care, oncology, and rare disease.

    Media Contact

    Phil LeClare
    Magnetude Consulting on behalf
    of Herspiegel
    phil@magnetude.com
    617-209-9406

    Let's Talk

    Herspiegel is a leading professional services firm helping biotech start-ups and the world’s largest pharmaceutical companies navigate the path from science to brand performance and change patients’ lives. We are committed to using strategic insights from medical to commercial to market access to solve critical problems.